DJAM:XETRA:XETRA-Lyxor UCITS ETF Dow Jones Industrial Average (EUR)

ETF | Others |

Last Closing

USD 358.85

Change

0.00 (0.00)%

Market Cap

USD 0.31B

Volume

6.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.11 (-0.21%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.03 (-0.18%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.12 (-0.44%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.14 (-0.49%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.36%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.10 (-0.07%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.08%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.40 (+0.28%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.09 (-0.17%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.84 (+0.55%)

USD 80.38B

ETFs Containing DJAM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.90% 53% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.90% 52% F 54% F
Trailing 12 Months  
Capital Gain 17.60% 69% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.60% 69% C- 70% C-
Trailing 5 Years  
Capital Gain 52.02% 73% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.02% 73% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.25% 74% C 71% C-
Dividend Return 9.76% 75% C 71% C-
Total Return N/A 13% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 11.82% 54% F 63% D
Risk Adjusted Return 82.62% 94% A 94% A
Market Capitalization 0.31B 57% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.